Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26F20EW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,789
Award facts
- Contract value 100% obligated
- $42,789.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,789.24 delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Gamunex-C 20 gram/200 mL vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The product is to be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of January 27, 2026. Gamunex-C is an intravenous immunoglobulin (IVIG) therapy used to treat immunodeficiency disorders and other immune-related conditions, representing a critical pharmaceutical commodity for military healthcare systems.
This delivery order is a child contract under AmerisourceBergen's broader $999.9 billion IDC with DLA, which serves as a comprehensive pharmaceutical prime vendor vehicle enabling the company to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal procurement portfolio demonstrates substantial capability in meeting specialized medical supply requirements across multiple therapeutic domains for defense and veteran healthcare systems. The company maintains contracts with major federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, positioning it as a critical vendor within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F20EW?
SPE2DR26F20EW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F20EW worth?
The government has obligated $42,789 on SPE2DR26F20EW.
Is contract SPE2DR26F20EW an order under another contract?
Yes. SPE2DR26F20EW is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F20EW competed?
The extent of competition for SPE2DR26F20EW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award